You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: September 25, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021749

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

NDA 021749 describes PENTETATE CALCIUM TRISODIUM, which is a drug marketed by Hameln Pharma Plus and is included in one NDA. It is available from one supplier. Additional details are available on the PENTETATE CALCIUM TRISODIUM profile page.

The generic ingredient in PENTETATE CALCIUM TRISODIUM is pentetate calcium trisodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the pentetate calcium trisodium profile page.
Summary for 021749
Applicant:Hameln Pharma Plus
Ingredient:pentetate calcium trisodium
Formulation / Manufacturing:see details
Pharmacology for NDA: 021749
Mechanism of ActionLead Chelating Activity
Suppliers and Packaging for NDA: 021749
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PENTETATE CALCIUM TRISODIUM pentetate calcium trisodium SOLUTION;INHALATION, INTRAVENOUS 021749 NDA hameln pharma plus gmbh 70651-001 70651-001-03 10 AMPULE in 1 PACKAGE (70651-001-03) > 5 mL in 1 AMPULE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INHALATION, INTRAVENOUSStrengthEQ 1GM BASE/5ML (EQ 200MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Aug 11, 2004TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.